Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $110.9800 (-0.46%) ($108.6200 - $114.8300) on Tue. Jun. 16, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.19% (three month average) | RSI | 60 | Latest Price | $110.9800(-0.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -2.2% a day on average for past five trading days. | Weekly Trend | LGND advances 2.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(50%) IWC(47%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -2.595% in a week (0% probabilities). VIXM(-23%) UUP(-17%) VXX(-15%) UNG(-3%) IYT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.595% (StdDev 5.19%) | Hourly BBV | 0 () | Intraday Trend | -3.4% | | | |
|
5 Day Moving Average | $111.96(-0.88%) | 10 Day Moving Average | $116.4(-4.66%) | 20 Day Moving Average | $110.83(0.14%) | To recent high | -10.2% | To recent low | 75.1% | Market Cap | $1.784b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |